U.S. Online Retail and Ecommerce Stock News

Danaher Corporation recently presented at the BIO-Europe Spring 2026 conference in Lisbon on March 24, 2026, with Senior Director Luciano Lucas speaking to an audience focused on biopharma partnering and innovation. This appearance gives Danaher a platform to highlight its life sciences tools and diagnostics capabilities to prospective collaborators and customers in a highly specialized setting. We’ll now examine how Danaher’s BIO-Europe Spring presentation, emphasizing its life sciences and...

Jack Henry & Associates (JKHY) is back in focus after Zelle expanded its Minority Depository Institution access program through a new partnership with the fintech provider, and Independent Bancshares Inc. selected Jack Henry to upgrade its core technology. See our latest analysis for Jack Henry & Associates. Despite the recent Zelle expansion and new bank wins, Jack Henry & Associates' 1-day share price return of 2.04% comes after a weaker patch, with a 90-day share price return of a 15.24%...

Virgin Galactic Holdings (SPCE) has created a new Chief Growth Officer role and appointed Megan Prichard. She has been tasked with leading revenue and expansion efforts across spaceflight expeditions, research missions, spaceports, partnerships, and new commercial markets. See our latest analysis for Virgin Galactic Holdings. The share price has retreated to US$2.17, with a 30 day share price return of a 14.90% decline and a 34.24% decline over 90 days. The 5 year total shareholder return of...

Ultragenyx Pharmaceutical (RARE) recently reported that the U.S. Food and Drug Administration cleared its Investigational New Drug application for UX016, a potential substrate replacement therapy for GNE myopathy, and a Phase 1/2 study is planned for 2026. See our latest analysis for Ultragenyx Pharmaceutical. Despite the UX016 milestone, the recent 30 day share price return of 17.49% decline and year to date share price return of 18.22% decline sit against a 1 year total shareholder return...

GameStop Corp. recently reported results for the fourth quarter and full year ended January 31, 2026, with quarterly sales of US$1,104.3 million versus US$1,282.6 million a year earlier and quarterly net income of US$127.9 million versus US$131.3 million. Despite lower sales both in the quarter and across the full year, full-year net income rose to US$418.4 million, lifting earnings per share from continuing operations compared with the prior year. Next, we’ll examine how GameStop’s higher...

Tokenization could enable faster settlement, increased liquidity and broader global investor access for Eva Live.

Missile attacks on major Middle East aluminum producers have disrupted material supply and pushed aluminum prices higher in recent days. These disruptions are drawing fresh attention to US based producer Alcoa (NYSE:AA) as investors reassess supply risk and potential margin effects. The renewed focus comes after earlier commentary around aluminum markets centered on easing supply and related price pressure. For Alcoa at a share price of $63.22, the new supply shock lands on top of a strong...

If you are wondering whether USA Compression Partners at around US$27.29 is priced attractively or not, the key is to separate share price excitement from underlying value. The unit price is down 2.4% over the last 7 days and 0.1% over the last 30 days, yet it still shows a 14.7% return year to date and 10.3% over the past year, with longer term returns of 66.1% over 3 years and 207.2% over 5 years. These moves sit against a backdrop of ongoing interest in energy infrastructure partnerships...

Guardian Investigate launch puts Cellebrite DI (CLBT) in focus Cellebrite DI (NasdaqGS:CLBT) is drawing fresh attention after launching Guardian Investigate worldwide, an AI-powered case management tool designed to help law enforcement teams organize, analyze and collaborate on complex digital investigations. See our latest analysis for Cellebrite DI. The Guardian Investigate launch comes after a mixed period for the stock, with a 1-day share price return of 2.16% to US$13.23, a 90-day share...

Merck (NYSE:MRK) reported positive Phase 3 results for its oral PCSK9 inhibitor, enlicitide decanoate, showing marked LDL C reduction and a favorable safety profile. The company also released Phase 2 WINREVAIR data in combined post and precapillary pulmonary hypertension with heart failure, supporting further clinical development. These readouts highlight potential franchise expansion for Merck in cardiovascular and cardiopulmonary diseases, extending beyond its existing oncology focus. For...

Worthington Steel, Inc. has already reported its third-quarter and nine-month results to February 28, 2026, showing higher sales of US$769.8 million for the quarter and US$2.51 billion for nine months, but with quarterly net income easing to US$10.4 million while nine‑month earnings improved to US$66 million; the board also declared a US$0.16 per‑share dividend payable on June 26, 2026. The mix of rising revenue but softer quarterly profitability, alongside a maintained dividend, highlights...

GBank Financial Holdings (GBFH) just closed out FY 2025 with fourth quarter revenue of US$20.9 million and basic EPS of US$0.52, supported by trailing twelve month revenue of US$72.2 million and EPS of US$1.46. Over recent periods, quarterly revenue has moved from US$16.2 million in Q4 2024 to US$20.9 million in Q4 2025, while quarterly EPS shifted from US$0.37 to US$0.52. This may prompt investors to focus on how earnings power and profit margins are holding up. See our full analysis for...

ADMA Biologics (ADMA) moved back into focus after its shares climbed about 11% following a detailed rebuttal to a short seller report that questioned ASCENIV demand and alleged aggressive distribution practices. See our latest analysis for ADMA Biologics. That sharp 11% rebound sits against a weak recent trend, with a 30-day share price return of 41.23% and a year to date share price return of 48.83%. At the same time, the 3-year total shareholder return of about 1.8x and 5-year total...

Wondering if Constellation Energy at around US$298 a share is priced for perfection or still offers value? This article breaks down what the current market price might be saying about the stock. The share price is up 1.3% over the past week, after a 9.5% decline over 30 days and an 18.5% pullback year to date, while the 1 year return sits at 45.0% and the 3 year return at 301.7%. Recent headlines around Constellation Energy have focused on its role in the US power market and investor...

What recent performance says about CleanSpark CleanSpark (CLSK) has been trading under pressure, with the share price down about 5% over the past day and roughly 18% over the past week, month, and past 3 months. Against that shorter term weakness, the stock still shows a 1 year total return of about 22% and a very large 3 year total return multiple, while the 5 year total return reflects a decline over the longer stretch. See our latest analysis for CleanSpark. The recent 1 day and 90 day...

Event driven snapshot of Versigent Versigent (VGNT.WI) recently attracted attention after its when-issued shares closed at $31.00, giving the Switzerland based Aptiv subsidiary a market value of about $2.1 billion in electrical distribution solutions. See our latest analysis for Versigent. That 2.65% 1 day share price return, with the share price at $31.00, sets the tone for Versigent’s early trading and may indicate that investors are adjusting expectations around its role in electrical...

In recent weeks, Comcast has expanded its multi-gigabit, symmetrical Internet footprint to thousands of additional homes and businesses across New Hampshire, Pennsylvania, West Virginia, and Florida, while also launching a new all-in-one connectivity and cybersecurity suite for small firms through Comcast Business. These moves highlight how Comcast is using both physical network buildouts and higher-value bundled services to deepen residential reach and embed itself more firmly in small...

Carrier Global’s recent performance snapshot Carrier Global (CARR) has been on many investors’ radar after a mixed stretch, with a modest 0.2% gain over the past day and a 6.8% decline over the past week. Over the past month, the stock shows a 15.6% decline, while the past 3 months reflect a 1.7% gain, leaving the 1-year total return at a 13.0% decline. See our latest analysis for Carrier Global. At a share price of $54.36, Carrier Global’s recent 30-day share price return of a 15.6% decline...

Wondering if Chevron's current share price really reflects its underlying value, or if the market is overlooking something you might care about? The stock last closed at US$210.71, with returns of 2.7% over 7 days, 12.8% over 30 days, 35.2% year to date, 31.6% over 1 year, 40.8% over 3 years, and 148.3% over 5 years, which suggests that valuation is front of mind for many investors. Recent headlines have focused on Chevron's position in the global energy sector and its capital allocation...

Satellogic (SATL) has drawn fresh attention after unveiling Merlin, a planned constellation designed for daily global remapping at one-meter resolution. The project aims to support large scale monitoring across commercial and defense intelligence use cases. See our latest analysis for Satellogic. Those Merlin plans sit alongside a sharp 168.65% 90 day share price return and a 153.57% year to date share price return. The 1 year total shareholder return of 39.22% suggests momentum has recently...

Stanley Black & Decker (SWK) is on investors’ radar after recent share weakness, with the stock down about 22% over the past month and roughly 10% over the past 3 months. See our latest analysis for Stanley Black & Decker. The recent 22% 30-day share price decline comes on top of an 11.8% year-to-date share price fall, while the 1-year total shareholder return of 8.1% and 5-year total shareholder return of 60.4% point to momentum that has been fading over time. If you are reassessing your...

If you are wondering whether Intuitive Surgical's current share price still makes sense for your portfolio, it helps to break the story into what the stock has done recently and what the numbers say about value. The stock closed at US$452.78, with returns of 5.3% decline over 7 days, 10.1% decline over 30 days, 19.4% decline year to date and 8.6% decline over 1 year, set against longer term returns of 78.6% over 3 years and 77.3% over 5 years. Recent headlines around robotic surgery...

If you are wondering whether Citigroup at around US$107 per share still offers value or if most of the opportunity has already played out, the recent share price history gives you some useful clues. The stock has pulled back, with a 3.9% decline over the last 7 days and a 2.6% decline over 30 days. It also sits on a 55.0% return over 1 year and 154.9% over 3 years, which can change how investors think about both upside potential and risk. Recent news around Citigroup has largely focused on...

Recent performance snapshot for General Motors (GM) General Motors (GM) has traded softer recently, with the stock showing a 0.3% decline over the past day, a 3.9% decline over the past week, and a 7.6% decline over the past month. See our latest analysis for General Motors. While the 30 day share price return of 7.6% and 90 day share price return of 11.6% point to fading near term momentum, General Motors still has a 1 year total shareholder return of 56.3% and a 3 year total shareholder...